Journals
Publish with us
Publishing partnerships
About us
Blog
Evidence-Based Complementary and Alternative Medicine
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Evidence-Based Complementary and Alternative Medicine
/
2021
/
Article
/
Fig 1
/
Review Article
Advances of Antisense Oligonucleotide Technology in the Treatment of Hereditary Neurodegenerative Diseases
Figure 1
ASOs recruit RNase H to degrade target RNA.
